Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CTKB will decline by -4.51% over the next 2 Weeks and hit $4.09 by Tuesday, August 18, 2026. In that time frame, CTKB's share price is expected to range between $3.93 and $4.25.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 18, 2026 | 3.93 | 4.09 | 4.25 |
| Aug 17, 2026 | 3.91 | 4.05 | 4.20 |
| Aug 14, 2026 | 4.01 | 4.16 | 4.31 |
| Aug 13, 2026 | 4.03 | 4.18 | 4.32 |
| Aug 12, 2026 | 4.04 | 4.18 | 4.31 |
| Aug 11, 2026 | 4.07 | 4.20 | 4.34 |
| Aug 10, 2026 | 4.03 | 4.16 | 4.29 |
| Aug 7, 2026 | 4.14 | 4.28 | 4.41 |
| Aug 6, 2026 | 4.16 | 4.29 | 4.42 |
| Aug 5, 2026 | 4.15 | 4.29 | 4.42 |
CTKB shares fell -0.70% in Tuesday, August 4, 2026's trading session, dropping from a previous close of $4.31 to move at $4.28. The stock demonstrated notable intraday movement (see CTKB's key stats for a full breakdown), fluctuating between $4.17 and $4.36, a +4.60% trading range. While recent weeks have seen some volatility, CTKB has managed to secure a -5.73% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 819.17K shares changing hands, 70.73K fewer than the previous session. This amounted to $3.51M in total market activity.
Will CTKB Continue Its Downward Trend?
According to analyst ratings and projections for CTKB, Cytek Biosciences, Inc. shares are anticipated to decrease by -0.75%, potentially reaching $4.25 per share by August 18, 2026. Short-term technical indicators currently suggest a neutral sentiment for CTKB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the CTKB stock forecast, now is not the best time to buy CTKB stock because its current trading price is +4.72% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CTKB covering social and institutional perspectives.
CTKB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CTKB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 37.83% to 46.62%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.93%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.33%, maintains a neutral outlook for the long term. Insights into CTKB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Cytek Biosciences Short-Term Forecasts
CTKB Forecast For Next 5 Days
Our algorithm anticipates Cytek Biosciences (CTKB) stock could hit $3.93 by Aug 11, 2026. This represents a -8.12% fall from today's price, following a -8.45% change over the past five days.
CTKB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Cytek Biosciences, Inc. (CTKB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $4.27, which would mean a -0.23% decrease from the current price of $4.28. Projections for this period range from a high of $5.13 to a low of $3.47.
CTKB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Cytek Biosciences's price over the next three months point to a rise. CTKB stock is expected to peak at $14.25 on Aug 18, 2026 before potentially dipping to $9.50 on Oct 15, 2026. On average, CTKB is likely to trade around $12.10 in the coming 90 days.
Cytek Biosciences Stock Forecast 2025
Based on our predictive models, Cytek Biosciences (CTKB) is expected to trade between $9.50 and $17.95 throughout 2026. This would result in an average price of $13.49, potentially offering investors a +215.19% return from current levels.
Cytek Biosciences, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Cytek Biosciences, Inc. (CTKB) is positioned to show a strong performance in August 2026. The price is predicted to move between $12.55 and $14.25, settling at an average of $13.31. This could translate to a +210.98% gain.
September 2026
Based on current market signals, Cytek Biosciences, Inc. is projected to trend september 2026. We forecast a trading range from $11.24 to $13.33, with a likely average price of $12.46. Investors could expect a potential return of +191.12%.
October 2026
Our predictive algorithms indicate Cytek Biosciences, Inc. stock may see a shift in October 2026. The expected range spans $9.50–$11.98, with an average target of $10.54. This represents a positive outlook and a possible gain of +146.26%.
November 2026
Analyzing established trends, Cytek Biosciences, Inc. looks set to move in November 2026. Projections place the stock between $12.11 and $17.95, averaging around $15.35. This suggests a +258.64% gain from current levels.
December 2026
Market indicators suggest Cytek Biosciences, Inc. could experience notable changes during December 2026. Prices could fluctuate within $13.49 to $17.72, with a midpoint forecast of $15.72. The stock might deliver a +267.29% gain.
January 2027
Forecasting for January 2027, models estimate that Cytek Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $12.01 and $18.28, averaging $15.67. This signals a positive trajectory with potential returns around +266.12%.
February 2027
According to our latest forecast models, Cytek Biosciences, Inc. (CTKB) is positioned to show a strong performance in February 2027. The price is predicted to move between $10.55 and $17.06, settling at an average of $14.53. This could translate to a +239.49% gain.
March 2027
Based on current market signals, Cytek Biosciences, Inc. is projected to trend march 2027. We forecast a trading range from $8.50 to $15.39, with a likely average price of $12.12. Investors could expect a potential return of +183.18%.
April 2027
Our predictive algorithms indicate Cytek Biosciences, Inc. stock may see a shift in April 2027. The expected range spans $8.44–$17.22, with an average target of $13.29. This represents a positive outlook and a possible gain of +210.51%.
May 2027
Analyzing established trends, Cytek Biosciences, Inc. looks set to move in May 2027. Projections place the stock between $5.92 and $15.91, averaging around $10.97. This suggests a +156.31% gain from current levels.
June 2027
Market indicators suggest Cytek Biosciences, Inc. could experience notable changes during June 2027. Prices could fluctuate within $6.34 to $18.29, with a midpoint forecast of $12.57. The stock might deliver a +193.69% gain.
July 2027
Forecasting for July 2027, models estimate that Cytek Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $5.99 and $19.74, averaging $13.53. This signals a positive trajectory with potential returns around +216.12%.
August 2027
According to our latest forecast models, Cytek Biosciences, Inc. (CTKB) is positioned to show a strong performance in August 2027. The price is predicted to move between $5.55 and $18.68, settling at an average of $12.80. This could translate to a +199.07% gain.
CTKB's history of dividends and stock splits also plays a role in long-term investor confidence.